Neoplasia/BPH

	Carboplatin, Cabazitaxel and Abiraterone in High-Volume Metastatic Castration-Sensitive Prostate Cancer: The CASCARA Phase 2 Study. Clin Cancer Res Antonarakis ES, Cao Q, Catharine V, Carneiro BA, De Souza AL, VanderWeele DJ, Singh P, Bryce AH, Kelly WK, Jha GG, Lewis B, Barata PC, Sartor AO, Stadler WM, Proudfoot JA, Davicioni E, Dhawan M, Morgans AK, Ryan CJ. PMID: 41880596 [PubMed - as supplied by publisher]
	Use of a Delphi process to formulate a pragmatic framework for care planning in older adults with advanced bladder cancer. Support Care Cancer Kessler ER, Hoover K, Coats H, Fischer SM. PMID: 41880032 [PubMed - indexed for MEDLINE]
	[Perioperative therapy for muscle-invasive bladder cancer-current treatment concepts]. Urologie Niegisch G, Gakis G, Ohlmann CH, Knüchel-Clarke R, Beyersdorff D, Rick O, Golka K, Hegemann M, Goebell PJ, Maisch P, Gschwend J. PMID: 41879995 [PubMed - as supplied by publisher]
	Correction to: Addition of quantitative imaging parameters to visual analysis improves the accuracy of PSMA PET/CT for the local staging of primary prostate cancer. Eur J Nucl Med Mol Imaging Donswijk ML, Ettema RH, Wondergem M, Cheung Z, van der Poel HG, Oprea-Lager DE, Vis AN. PMID: 41879990 [PubMed - as supplied by publisher]
	Nationwide population-based longitudinal data on magnetic resonance imaging of the prostate and subsequent prostate biopsy results. Scand J Urol Ventimiglia E, Gedeborg R, Westerberg M, Zaurito P, Jäderling F, Stattin P, Garmo H. PMID: 41879676 [PubMed - indexed for MEDLINE]
	Midterm Outcomes of Combination Therapy With Immune Checkpoint Inhibitors and VEGFR-TKIs in Real-World Patients With Advanced Renal Cell Carcinoma. Int J Urol Ishihara H, Katsurayama N, Nemoto Y, Mizoguchi S, Nakayama T, Fukuda H, Shimmura H, Hashimoto Y, Yoshida K, Iizuka J, Kondo T, Takagi T. PMID: 41879266 [PubMed - indexed for MEDLINE]
	Real-world precision medicine data in metastatic prostate cancer - a retrospective cohort study. Front Oncol Paracha A, Tran D, Noyelle M, Kapilian J, Siddiqui Z, Choppa A, Corsi A, Stone J, Zhu XH. PMID: 41878526 [PubMed]
	Effect of co-occurring mutations in TP53 gene and TERT promoter on the survival of bladder cancer patients. Front Immunol Tornesello ML, Piccirillo MC, Tambaro R, Simeon V. PMID: 41878440 [PubMed - indexed for MEDLINE]
	Multicentre Evaluation of an AI-Assisted Urine Test for Clinically Significant Prostate Cancer in Men Undergoing Initial Biopsy. J Extracell Vesicles Jiang S, Yang C, Huang Z, Guo Z, Lu F, Nian X, Chen Z, Luo P, Jiang J, Gao X, Li M, Liu F. PMID: 41877634 [PubMed - indexed for MEDLINE]
	Empirically derived dietary patterns and prostate cancer risk: a systematic review and meta-analysis of prospective cohorts. Eur J Cancer Prev Ben Souilah F, Tourigny R, Drouin-Chartier JP, Diorio C, Fradet V. PMID: 41877536 [PubMed - as supplied by publisher]
	Deciphering double-negative prostate cancer: from aggressive subtype to novel therapeutic paradigms. Cell Commun Signal Wang J, Wu R, Tuo Z, Okoli UA, Wang Z, Chaipanichkul P, Koh SB, Li D, Lyu Z, Umber C, Zhang Q, Feng D. PMID: 41877195 [PubMed - as supplied by publisher]
	Stage-specific associations of HER2 overexpression with clinical and pathological features in bladder cancer: a systematic review and meta-analysis. Int Urol Nephrol Guo C, Wei J, Wang Y, Zhang L, Wu X, Sheng X. PMID: 41876828 [PubMed - as supplied by publisher]
	Evaluating the safety profile of Î±-1 blockers, 5Î±-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS). Aging Male Zhao Z, Wu C, Xiong Y, Wang W, Qin F, Yuan J. PMID: 41876378 [PubMed - indexed for MEDLINE]
	Characterization of Immune Infiltrating Cells in Bladder Urothelial Carcinoma and Its Clinical Significance. Cancer Med Yan X, Tang X, Guo L, He Z, Liu S, Wu S, Li Z, Liu TZ, Zheng H, Zhang W, Li S. PMID: 41876361 [PubMed - indexed for MEDLINE]
	Two-year toxicity and PSA dynamics in the initial cohort of the SABR-Dual trial - two-fraction stereotactic radiotherapy for localized prostate cancer using rectal spacing. Radiother Oncol Fredman E, Attrash M, Yosefof E, Moore A, Tschernichovsky R, Bragilovski D, Weinstock-Sabbah M, Kindler J, Azuz RD, Radus R, Icht O, Golan S, Shochet T, Limon D. PMID: 41876028 [PubMed - as supplied by publisher]
	[Early Detection of Prostate Cancer: Current Real-World Data from the VERSUS Study by d-uo]. Aktuelle Urol Doehn C, König F, Johannsen M, Eichenauer R, Schönfelder R, Doehn ML, Schröder J, Hempel E, Klier J. PMID: 41875916 [PubMed - as supplied by publisher]
	AI chatbots for patient education in localized prostate cancer radiotherapy: A comparative quality and readability analysis. Patient Educ Couns Ozturk GA, Tumer EG, Çoban FSK, Ozturk H, Gurlek U, Ozturk M, Demirci H. PMID: 41875785 [PubMed - as supplied by publisher]
	Potential of the signature index (S-index), a diffusion MRI Biomarker, to enhance diagnosis of clinically significant prostate cancer and decrease the rate of unnecessary biopsies. Eur J Radiol Wibulpolprasert P, Bihan DL, Leelarujijaroen P, Kampaengtip A, Kijvikai K, Worawichawong S, Phongkitkarun S. PMID: 41875674 [PubMed - as supplied by publisher]
	A Culturally Tailored Mobile Health Intervention to Improve Quality of Life in Black Survivors With Prostate Cancer: Protocol for a Stratified Randomized Controlled Trial. JMIR Res Protoc Kumar G, Ghasemi P, Alexander AC, Dwyer K, Neil JM, Cole P, Beckford P, Reese D, Montgomery E, Odeleye R, Harris MA, Zhao YD, Nagykaldi Z, McIntosh AG, Kaninjing E, Young ME, Dickey S, Morton DJ, Bolajoko O, Odedina FT, Planas LG, Businelle MS, Kendzor DE, Ogunsanya ME. PMID: 41875429 [PubMed - indexed for MEDLINE]
	Repositioning the Digital Rectal Examination in the Era of Risk-Adapted Prostate Can-cer Diagnostics: Right Tool to the Right Patient at the Right Time. Int Braz J Urol Reis LO. PMID: 41875312 [PubMed - in process]

Articles 1 - 20 / 186562

Page 1 of 9329



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy